Plaisance-Bonstaff Karlie, Renne Rolf
Department of Molecular Genetics and Microbiology, University of Florida Shands Cancer Center, University of Florida, Gainesville, FL, USA.
Methods Mol Biol. 2011;721:43-66. doi: 10.1007/978-1-61779-037-9_3.
Since 2004, more than 200 microRNAs (miRNAs) have been discovered in double-stranded DNA viruses, mainly herpesviruses and polyomaviruses (Nucleic Acids Res 32:D109-D111, 2004). miRNAs are short 22 ± 3 nt RNA molecules that posttranscriptionally regulate gene expression by binding to 3'-untranslated regions (3'UTR) of target mRNAs, thereby inducing translational silencing and/or transcript degradation (Nature 431:350-355, 2004; Cell 116:281-297, 2004). Since miRNAs require only limited complementarity for binding, miRNA targets are difficult to determine (Mol Cell 27:91-105, 2007). To date, targets have only been experimentally verified for relatively few viral miRNAs, which either target viral or host cellular gene expression: For example, SV40 and related polyomaviruses encode miRNAs which target viral large T antigen expression (Nature 435:682-686, 2005; J Virol 79:13094-13104, 2005; Virology 383:183-187, 2009; J Virol 82:9823-9828, 2008) and miRNAs of α-, β-, and γ-herpesviruses have been implicated in regulating the transition from latent to lytic gene expression, a key step in the herpesvirus life cycle. Viral miRNAs have also been shown to target various host cellular genes. Although this field is just beginning to unravel the multiple roles of viral miRNA in biology and pathogenesis, the current data strongly suggest that virally encoded miRNAs are able to regulate fundamental biological processes such as immune recognition, promotion of cell survival, angiogenesis, proliferation, and cell differentiation. This chapter aims to summarize our current knowledge of viral miRNAs, their targets and function, and the challenges lying ahead to decipher their role in viral biology, pathogenesis, and for γ-herepsvirus-encoded miRNAs, potentially tumorigenesis.
自2004年以来,已在双链DNA病毒中发现了200多种微小RNA(miRNA),主要是疱疹病毒和多瘤病毒(《核酸研究》32:D109 - D111,2004年)。miRNA是短的22 ± 3个核苷酸的RNA分子,通过与靶mRNA的3'非翻译区(3'UTR)结合在转录后调节基因表达,从而诱导翻译沉默和/或转录本降解(《自然》431:350 - 355,2004年;《细胞》116:281 - 297,2004年)。由于miRNA结合仅需要有限的互补性,因此难以确定miRNA的靶标(《分子细胞》27:91 - 105,2007年)。迄今为止,仅对相对较少的病毒miRNA进行了实验验证其靶标,这些靶标要么靶向病毒基因表达,要么靶向宿主细胞基因表达:例如,SV40及相关多瘤病毒编码的miRNA靶向病毒大T抗原表达(《自然》435:682 - 686,2005年;《病毒学杂志》79:13094 - 13104,2005年;《病毒学》383:183 - 187,2009年;《病毒学杂志》82:9823 - 9828,2008年),α、β和γ疱疹病毒的miRNA与调节从潜伏到裂解基因表达的转变有关,这是疱疹病毒生命周期中的关键步骤。病毒miRNA也已被证明靶向各种宿主细胞基因。尽管该领域刚刚开始揭示病毒miRNA在生物学和发病机制中的多种作用,但目前的数据强烈表明,病毒编码的miRNA能够调节免疫识别、促进细胞存活、血管生成、增殖和细胞分化等基本生物学过程。本章旨在总结我们目前对病毒miRNA及其靶标和功能的了解,以及在解读它们在病毒生物学、发病机制中的作用以及对于γ疱疹病毒编码的miRNA潜在的肿瘤发生作用方面所面临的挑战。